Literature DB >> 2807038

Extrinsic pathway inhibitor in postoperative/posttraumatic septicemia: increased levels in fatal cases.

P M Sandset1, O Røise, A O Aasen, U Abildgaard.   

Abstract

The activity of the extrinsic pathway inhibitor (EPI), which is the factor-Xa-dependent inhibitor of the factor VIIa-tissue thromboplastin complex, was serially determined in 13 patients with postoperative/posttraumatic septicemia, and compared to the activity of antithrombin (AT), heparin cofactor II and protein C (PC). In the survivors (n = 8), initial low values for all the inhibitors normalized during recovery. In the demises (n = 5), a progressive increase in EPI activity was observed until death, whereas progressive decreases were observed for the other inhibitors. No correlation was found between the inhibitor values and the endotoxin concentration. We conclude that EPI activities are increased in the late course of fatal septicemia. Apparently, a large EPI-AT gap is a severe prognostic indicator in such patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807038     DOI: 10.1159/000215916

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  5 in total

1.  Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

Authors:  F Baudo; T M Caimi; F de Cataldo; A Ravizza; S Arlati; G Casella; D Carugo; G Palareti; C Legnani; L Ridolfi; R Rossi; A D'Angelo; L Crippa; D Giudici; G Gallioli; A Wolfler; G Calori
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 2.  AT III in septicemia with DIC.

Authors:  H P Schuster
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

3.  Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.

Authors:  P M Sandset; B J Warn-Cramer; L V Rao; S L Maki; S I Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

4.  Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.

Authors:  Haiwang Tang; Lacramioara Ivanciu; Narcis Popescu; Glenn Peer; Erik Hack; Cristina Lupu; Fletcher B Taylor; Florea Lupu
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

5.  Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

Authors:  A A Creasey; A C Chang; L Feigen; T C Wün; F B Taylor; L B Hinshaw
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.